Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

Aichi Gakuin University20 enrolled

Overview

The purpose of this study is to evaluate the effects of Sarpogrelate in endothelial progenitor cells of patients with atherosclerosis.

Endothelial progenitor cells play an important role in vasculogenesis and vascular repair. Sarpogrelate, a inhibitor of HT2A, is used an an anti-platelet drug, however, a direct effect in vascular cells is supposed.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Atherosclerosis

Interventions

SarpogrelateDRUG

Sarpogrelate 300mg/day

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with atherosclerosis Exclusion Criteria: * Patients with high risk of bleeding * Patients with pregnancy * Patients with allergic reaction of Salpogrelate

Locations (1)

Aichi-Gakuin University

Nagoya, Aichi-ken, Japan

RECRUITING

Outcomes

Primary Outcomes

The number and function of endothelial progenitor cells

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.